Scientific Program

Scientific Program Objectives

  • Discuss the latest advances to improve cord blood transplantation and the successful development of novel therapies for the treatment of non-hematologic diseases.
  • Identify differing approaches to commercialization and strategies to create new business models.
  • Evaluate the current industry and technological advances in perinatal cell and tissue processing, storage and potential applications in the clinic.
  • Understand the changing legislation of 21st Century Cures and its potential effect on the banking, transplant and regenerative medicine industries.


View the Scientific Program.

StemCyte, Inc. China CordBlood Corporation National Marrow Donor Program/Be the Match

Support provided by